Neutral endopeptidase
Alternative Names: NEP; rNEPLatest Information Update: 24 Oct 2021
At a glance
- Originator Genentech
- Class Anti-inflammatories; Antiasthmatics; Antimigraines; Antineoplastics
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammatory bowel diseases; Lung cancer; Migraine; Small cell lung cancer
Most Recent Events
- 04 Oct 2006 Discontinued - Preclinical for Asthma in USA (unspecified route)
- 04 Oct 2006 Discontinued - Preclinical for Inflammatory bowel disease in USA (unspecified route)
- 04 Oct 2006 Discontinued - Preclinical for Lung cancer in USA (unspecified route)